Increasing evidence has demonstrated ATBF1 as a strong candidate tumor suppressor gene in multiple tumors, including prostate cancer [1, 5], gastric cancer [6], liver cancer [7], colon cancer [8] and non-small cell lung cancer [9]. This evidence concerns the gene ZFHX3 and prostate carcinoma.